• We are aware that a lawsuit was filed by Pfizer Inc. against us and some of our executives on February 2, 2022. We believe that the lawsuit is entirely meritless and will defend ourselves vigorously.



    About Regor Therapeutics Group

    Regor Therapeutics Group is a clinical stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary rCARDTM (Computer Accelerated Rational Discovery) Platform. The company focuses mainly on three therapeutic areas, oncology, immunology, and metabolic disorders. By seamlessly integrating rCARDTM with structural biology, computational biology, computational chemistry and other disciplines, Regor has successfully assembled a world-class scientific team and established a highly efficient new drug innovation engine to enable the discovery and development of best- and first-in-class molecules. To learn more about Regor, please visit us at www.regor.com.

    Media Contact:

      Lauren Xuan

      Email: lili.xuan@qlregor.com



245 Main Street, Second Floor, Cambridge, MA 02142, USA
1206 Zhangjiang Rd, Building C, Pudong New District, Shanghai 201210, China